Oncology & Immunology Innovation Partnering & Licensing Summit 2026

 

For biotech across ADCs, TCEs, BsAbs, TPD, and in vivo CAR-T, competing to align earlier clinical proof-of-concept data with pharma expectations, the Oncology & Immunology Innovation Partnering & Licensing Summit is the gateway to multiple high-impact, in-person meetings – without the distractions of a more diverse setting.

Designed around pharma teams scouting best-or-first-in-class candidates to compare competitive assets and technologies against a scientifically relevant context, this is the best opportunity in your conference calendar to remain relevant with the right decision-makers.

Through a dedicated one-to-one partnering system, organized matchmaking, and total audience alignment, pharma can efficiently meet, provide feedback on, and compare licensing and co-development opportunities, whilst biotech business development can cut through the noise and competition to secure guaranteed meetings with key stakeholders.

Join us this September to refine your strategy, sharpen your positioning, and understand expectations for deal conversations.

More Info

---

---